- Home
- TAC vs CPRX Comparison
TAC vs CPRX Comparison
Compare TAC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAC
- CPRX
- Stock Information
- Founded
- TAC 1909
- CPRX 2002
- Country
- TAC Canada
- CPRX United States
- Employees
- TAC N/A
- CPRX N/A
- Industry
- TAC Electric Utilities: Central
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- TAC Utilities
- CPRX Health Care
- Exchange
- TAC Nasdaq
- CPRX Nasdaq
- Market Cap
- TAC 3.2B
- CPRX 2.6B
- IPO Year
- TAC N/A
- CPRX 2006
- Fundamental
- Price
- TAC $12.29
- CPRX $20.59
- Analyst Decision
- TAC Buy
- CPRX Strong Buy
- Analyst Count
- TAC 3
- CPRX 5
- Target Price
- TAC $19.83
- CPRX $33.20
- AVG Volume (30 Days)
- TAC 1.1M
- CPRX 1.5M
- Earning Date
- TAC 08-01-2025
- CPRX 08-06-2025
- Dividend Yield
- TAC 1.61%
- CPRX N/A
- EPS Growth
- TAC N/A
- CPRX 183.96
- EPS
- TAC N/A
- CPRX 1.65
- Revenue
- TAC $1,838,165,207.00
- CPRX $558,499,000.00
- Revenue This Year
- TAC N/A
- CPRX $16.51
- Revenue Next Year
- TAC N/A
- CPRX $9.58
- P/E Ratio
- TAC N/A
- CPRX $12.45
- Revenue Growth
- TAC N/A
- CPRX 28.55
- 52 Week Low
- TAC $7.82
- CPRX $19.00
- 52 Week High
- TAC $14.64
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- TAC 53.10
- CPRX 48.79
- Support Level
- TAC $12.02
- CPRX $19.83
- Resistance Level
- TAC $12.66
- CPRX $21.82
- Average True Range (ATR)
- TAC 0.30
- CPRX 0.57
- MACD
- TAC -0.04
- CPRX 0.07
- Stochastic Oscillator
- TAC 46.38
- CPRX 45.33
About TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, Hydro, Wind & Solar, Energy Marketing, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).